CAR-T Cell therapypharmaceutical interventions
…gous transplants, 27 (32.1%) were allogeneic, and 2 (2.4%) were CAR-T Cell therapy.PRMPs were identified in 42.9% (n=36) of the prescriptions, wit…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 541–600 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Locoregional therapy3Pancreatic Enzyme Replacement Therapy3Peroral endoscopic myotomy3Pharmacologic treatment3Positive Airway Pressure (PAP) therapy3Regional analgesia3Traditional Chinese Medicine3Vitamin supplementation3advanced therapies3anti-PD1 therapy3anti-VEGF therapy3anti-programmed cell death protein-1 therapy3antiarrhythmic therapy3anticancer therapies3anticancer therapy3autologous stem cell transplantation3behavioural therapy3cancer therapies3chimeric antigen receptor T-cell therapy3clinical management3cognitive–behavioural therapy3conventional immunosuppression3coronary revascularisation3deworming3diabetes treatment3dopaminergic therapy3haematopoietic stem cell transplantation3immunotherapy treatment3inhaled corticosteroids3intensive care treatment3intravenous fluid therapy3intravenous iron therapy3lethal palliation3lifestyle changes3local anaesthesia3neurocritical care3novel therapies3nutritional support3occupational therapy3oral antibiotics3outpatient treatment3palliative chemotherapy3pharmacological interventions3physical rehabilitation3preventive measures3standard therapy3standard treatment3stent retriever thrombectomy3supportive treatment3surgical interventions3surgical management3symptomatic therapy3targeted treatment3topical therapy3tracheostomy3tyrosine kinase inhibitors3ultrasound-guided nerve blocks3vasodilator therapy3vasopressors3ventriculoperitoneal shunting3
Articles mentioning treatments
7,227 articles · page 391 of 603OPATceftazidimeanidulafunginertapenemcefepimeceftolozanepiperacillinamikacinmeropenemaztreonam+1 more
…n 7.6.Conclusion and Relevance A pharmacist-led TDM workflow in OPAT was feasible and safe, supported dose optimisation, and achieve…
intravenous infusionsInstitute for Safe Medication Practicesactive ingredient
…nary study conducted in a regional hospital in October 2024.All intravenous infusions administered in the medical and surgical adult inpatient units …
enteral nutritionamphotericin Bmeropenemampicillin–sulbactamlinezolidsepsisAcinetobacter baumannii
…ion, mechanical ventilation (tracheostomy on 25 September), and enteral nutrition. Empirical therapy with meropenem, linezolid, and amphotericin …
pharmacotherapyglycaemic decompensationhypertensive crisisgastrointestinal bleedinghypokalaemiaconstipationhypotensionhyperkalaemiaseizuresbradycardia+3 more
…ble strategy for prioritising interventions aimed at optimising pharmacotherapy and preventing further visits due to ADEs.Aim and Objectives To…
anti-infective therapyMEshaloperidolJoanna Briggs InstitutehypomagnesaemiaADEshypokalaemiaClinical Decision Support Systems
…atistically significant reductions, especially those related to anti-infective therapy or paediatrics. Forty studies analysed MEs, and all reported st…
pharmacotherapymajor depressionhypercholesterolaemiagastritisoesophagitishypertensionSpanish HospitalCEGEN-CNIO
…macogenetic testing in clinical practice allows optimisation of pharmacotherapy, particularly in polymedicated patients. In Spain, initiatives …
PrEPHIVnPEPnPEP-prescriptionsPrEPUNAIDShuman immunodeficiency virus
…interventions, as well as exposure scenarios not preventable by PrEP alone.Currently, many individuals who could benefit from PrEP r…
VMPMultiple myelomadaratumumablenalidomidebortezomibmelphalanprednisonedexamethasoneAnn OncolDaratumumab-based+4 more
…The addition of daratumumab (D) to standard first-line regimens–VMP (bortezomib/melphalan/prednisone) and Rd (lenalidomide/dexameth…
glucocorticoid therapyanakinratocilizumabdapsonecotrimoxazoleAdult-onset Still’s disease (AOSD)pentamidinePneumocystis jirovecii pneumoniamethylprednisoloneAOSD+3 more
…veloped severe dapsone-induced metahemoglobinemia. In May 2025, glucocorticoid therapy was initiated for pulmonary disease progression. Due to history…
antibiotic therapyurinary tract infectionsmedical training
…gh pharmacists are often involved in many committees related to antibiotic therapy, their participation in medical training on this subject has no…
Chimeric antigen receptor (CAR) T-cell therapiesAxicabtagene Ciloleuceltisagenlecleucellisocabtagene maraleucelR/R LBCL
…Background and Importance Chimeric antigen receptor (CAR) T-cell therapies have transformed the treatment landscape of relapsed/refractory…